ASA Monitor December 2023, Vol. 87, 18. Implant for thought-driven movement after spinal cord injury ONWARD Medical has conducted its first-in-human implant of the ARC-IM Stimulator, designed to restore upper-extremity movement and function in individuals with spinal cord injury (SCI). This new technology involves the use of a wireless brain-computer interface (BCI) to enable thought-driven movement […]
Read MoreAuthor: Toby N. Weingarten, MD Anesthesia Patient Safety Foundation Volume 38, No. 2 • June 2023 More than a decade ago the APSF established a clear edict: “No patient should be harmed by opioid-induced respiratory depression in the postoperative period.”1 Research studies established a strong association between obstructive sleep apnea (OSA) and adverse postoperative opioid-related outcomes. In […]
Read MoreASA Monitor December 2023, Vol. 87, 18. AI diagnosis of polycystic ovary syndrome A recent study by the National Institutes of Health reveals that artificial intelligence (AI) and machine learning (ML) are highly effective in detecting and diagnosing polycystic ovary syndrome (PCOS), the most common hormone disorder among women aged 15 to 45. Researchers reviewed 31 […]
Read MoreASA Monitor December 2023, Vol. 87, 18. Sedative with improved impact on cognitive function presented at SNACC Eagle Pharmaceuticals, Inc. was chosen for a platform presentation at the Society for Neuroscience in Anesthesiology and Critical Care Annual Meeting focusing on their sedative, remimazolam, and its potential impact on cognitive function during procedural sedation. Remimazolam is a […]
Read MoreASA Monitor December 2023, Vol. 87, 18. Gene variant in people with African ancestry associated with greater risks for Parkinson’s An NIH-funded international study recently discovered that the gene GBA1, found mostly in people of African ancestry, increases the risk of developing Parkinson’s disease. GBA1 provides instructions for building enzymes inside the lysosomes that help the […]
Read More